Cg Oncology Inc (NASDAQ:CGON) shares, rose in value, with the stock price up by 0.46% to the previous day’s close as strong demand from buyers drove the stock to $29.00.
Actively observing the price movement in the recent trading, the stock is buoying the session at $28.87, falling within a range of $27.58 and $29.95. Referring to stock’s 52-week performance, its high was $50.23, and the low was $25.77. On the whole, CGON has fluctuated by -17.49% over the past month.
With the market capitalization of Cg Oncology Inc currently standing at about $1.96 billion, investors are eagerly awaiting this quarter’s results, scheduled for in January.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 53.66k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CGON’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of CGON currently trading nearly -12.76% and -17.80% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 31.98, while the 7-day volatility ratio is showing 6.72% which for the 30-day chart, stands at 6.01%. Furthermore, Cg Oncology Inc (CGON)’s average true range (ATR) is 2.08.
Data on historical trading for Cg Oncology Inc (NASDAQ:CGON) indicates that the trading volumes over the past 10 days have averaged 0.65 and over the past 3 months, they’ve averaged 665.35K. According to company’s latest data on outstanding shares, there are 67.54 million shares outstanding.
Nearly 38.78% of Cg Oncology Inc’s shares belong to company insiders and institutional investors own 61.80% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.27 million shares as on 2024-11-29, resulting in a short ratio of 11.86. According to the data, the short interest in Cg Oncology Inc (CGON) stood at 786.00 of shares outstanding as of 2024-11-29; the number of short shares registered in 2024-10-31 reached 5.6 million. The stock has fallen by -21.97% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CGON stock heading into the next quarter.
